The Director of Retina Services at Wills Eye Hospital joins to discuss the historic FDA approval granted for a novel method of ophthalmic care: a permanent implant that allows for vision-saving formula therapy to treat the eye continually.

Read more about the PDS approval here.

Episode notes:
0:12 Intro

1:07 What is the Port Delivery System?

2:39 The history of developing the PDS

17:00 Is PDS exclusive to anti-VEGF?

19:52 Thoughts on the ranbizumab PDS approval

23:10 How will guidelines change?

24:15 Tips for best PDS use

26:30 Closing thoughts

29:40 Outro